Italia markets closed

RGEN May 2024 95.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,35000,0000 (0,00%)
In data: 04:51PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,3500
Aperto0,3000
Denaro0,0000
Lettera2,2000
Prezzo d'esercizio95,00
Scadenza2024-05-17
Min-Max giorno0,3000 - 0,3500
Contratto - Min-MaxN/D
Volume2
Open Interest14
  • GlobeNewswire

    Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

    Olivier Loeillot President and Chief Commercial Officer WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer (CCO), effective immediately. Mr. Loeillot served a combined 12 years with Cytiva (a Danaher company) and GE Healthcare Life Sciences

  • GlobeNewswire

    Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova

    Proposed acquisition adds market leading magnetic mixing technology for upstream and downstream bioprocess applicationsExpands Repligen’s Fluid Management portfolio, complements single-use bag offering WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a definitive agreement to acquire privately-held Metenova AB (Metenova) of Mölndal, Sweden. Meteno

  • GlobeNewswire

    Repligen Appoints Jason K. Garland as Chief Financial Officer

    WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed Jason K. Garland as Chief Financial Officer (“CFO”), effective September 25, 2023. Mr. Garland is joining Repligen from his most recent role with medical device outsource (MDO) manufacturer Integer Holdings Corporation (“Integer”), where he served for nearly five years (2018-2023) as Executive Vice Pre